QWM
EW icon

Quaker Wealth Management’s Edwards Lifesciences EW Stock Holding History

Quaker Wealth Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49.6K Buy
619
+7
+1% +$577 0.02% 162
2025
Q4 		$52.2K Buy
612
+1
+0.2% +$82 0.02% 162
2025
Q3 		$47.5K Hold
611
– – 0.02% 168
2025
Q2 		$47.8K Buy
+611
New +$45.6K 0.02% 164

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Quaker Wealth Management's EW Position: Q1 2026 in Review

Quaker Wealth Management increased its Edwards Lifesciences (EW) stake by 1.1% in Q1 2026, buying an estimated $577 and bringing the position to 619 shares worth $49.6K. The position accounts for 0.02% of the portfolio, ranked #162.

Quaker Wealth Management first reported a position in EW in Q2 2025 and has held it in 4 quarters since. The position peaked at $52.2K in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Quaker Wealth Management held 619 shares of Edwards Lifesciences worth $49.6K as of Q1 2026.
  • Quaker Wealth Management bought 7 Edwards Lifesciences shares in Q1 2026, an estimated $577.
  • Edwards Lifesciences made up 0.02% of Quaker Wealth Management's portfolio in Q1 2026, its #162 holding.
  • Quaker Wealth Management first reported a position in Edwards Lifesciences in Q2 2025 and has held it in 4 quarters since.
  • Quaker Wealth Management's Edwards Lifesciences position peaked at $52.2K in Q4 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Quaker Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.